标题:Omission of aspirin in patients taking oral anticoagulation after percutaneous coronary intervention: a systematic review and meta-analysis
作者:Zhang, Jian; Wang, Zheng; Sang, Wentao; Wei, Maozeng; Xu, Feng; Chen, Yuguo
作者机构:[Zhang, Jian; Wang, Zheng; Sang, Wentao; Wei, Maozeng; Xu, Feng; Chen, Yuguo] Shandong Univ, Qilu Hosp, Dept Emergency Med, Jinan, Shandong, Peoples R 更多
通讯作者:Xu, F
通讯作者地址:[Xu, F]Shandong Univ, Qilu Hosp, 107 Wen Hua Xi Rd, Jinan 250012, Shandong, Peoples R China.
来源:CORONARY ARTERY DISEASE
出版年:2019
卷:30
期:2
页码:109-115
DOI:10.1097/MCA.0000000000000698
关键词:acute coronary syndrome; atrial fibrillation; hemorrhage; myocardial; infarction; percutaneous coronary intervention
摘要:Background There is no consensus on optimal antiplatelet and anticoagulation therapy after coronary stenting.; Methods We identified randomized controlled trials (RCTs) published in PubMed, Cochrane Library, and Embase using the following keywords: 'antiplatelet', 'dual therapy', 'triple therapy', 'antithrombosis', 'indication for anticoagulation', 'percutaneous coronary intervention', and 'RCTs'. Primary safety end points were relative bleeding events, and secondary efficacy end points were major adverse cardiovascular events including stent thrombosis, death, myocardial infarction, and stroke.; Results We identified three RCTs including 5387 patients, of whom 2719 (50.5%) received dual therapy (DT) and 2668 (49.5%) received triple therapy. Relative to triple therapy, DTwas associated with lower Thrombolysis in Myocardial Infarction major bleeding [risk ratio (RR): 0.58; 95% confidence interval (CI): 0.42-0.82], Thrombolysis in Myocardial Infarction minor bleeding (RR: 0.46; 95% CI: 0.34-0.62), and clinical bleeding events (RR: 0.61; 95% CI: 0.47-0.81). There was no significant difference for the secondary efficacy end point. In subgroup analyses, results were similar by sex, bleeding risk, and stent type; however, DT appeared suitable for patients aged less than 75 years but not more than or equal to 75 years, implying that there may be no ideal therapy for patients older than 75 years to balance the risk of ischemia and bleeding at the same time.; Conclusion Among patients with an indication for oral anticoagulation after percutaneous coronary intervention, DT appears to be the optimal strategy. Copyright (c) 2019 Wolters Kluwer Health, Inc. All rights reserved.
收录类别:SCOPUS;SCIE
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060911913&doi=10.1097%2fMCA.0000000000000698&partnerID=40&md5=6173957df69d34e51c1f61a193dc93f9
TOP